12.26
Nurix Therapeutics Inc (NRIX) 最新ニュース
Needham Reiterates Buy Rating for NRIX, Maintains Price Target | - GuruFocus
What to expect from Nurix Therapeutics Inc. in the next 30 daysJuly 2025 Selloffs & Safe Entry Point Identification - newser.com
13 Analysts Have This To Say About Nurix Therapeutics - Benzinga
How sustainable is Nurix Therapeutics Inc. stock dividend payoutJuly 2025 News Drivers & Accurate Trade Setup Notifications - newser.com
BTIG Reiterates Buy Rating for Nurix Therapeutics (NRIX) with $2 - GuruFocus
Signal strength of Nurix Therapeutics Inc. stock in tech scannersVolume Spike & Weekly Chart Analysis and Trade Guides - newser.com
Is Nurix Therapeutics Inc. stock ready for breakoutJuly 2025 Breakouts & Precise Trade Entry Recommendations - newser.com
How moving averages guide Nurix Therapeutics Inc. trading2025 Price Action Summary & Intraday High Probability Setup Alerts - newser.com
Analyzing Nurix Therapeutics Inc. with risk reward ratio charts2025 Volatility Report & Real-Time Buy Zone Alerts - newser.com
Can Nurix Therapeutics Inc. stock hit record highs againWeekly Market Outlook & Free Real-Time Volume Trigger Notifications - newser.com
Why Nurix Therapeutics Inc. stock is a must watch in 2025July 2025 Action & Weekly Top Stock Performers List - newser.com
Applying chart zones and confluence areas to Nurix Therapeutics Inc.Weekly Gains Summary & Real-Time Volume Spike Alerts - newser.com
Insider Sell: Houte Van Sells Shares of Nurix Therapeutics Inc (NRIX) - GuruFocus
Nurix therapeutics CFO van Houte sells $78,931 in stock By Investing.com - Investing.com Canada
Full technical analysis of Nurix Therapeutics Inc. stockDividend Hike & Stepwise Swing Trade Plans - newser.com
Nurix Therapeutics Announces Presentations at the 67th American Society of Hematology (ASH) Annual Meeting - The Manila Times
Nurix (NASDAQ: NRIX) to present NX-5948 data in CLL and Waldenström at ASH - Stock Titan
Key metrics from Nurix Therapeutics Inc.’s quarterly dataWeekly Stock Recap & Detailed Earnings Play Alerts - newser.com
Is Nurix Therapeutics Inc. stock a buy for dividend growthBuy Signal & Momentum Based Trading Ideas - newser.com
Nurix Therapeutics Inc. stock daily chart insightsJuly 2025 Retail & AI Enhanced Trade Execution Alerts - newser.com
Can Nurix Therapeutics Inc. recover in the next quarterExit Point & Fast Exit and Entry Trade Guides - newser.com
Will Nurix Therapeutics Inc. stock deliver consistent dividendsWeekly Trend Report & Daily Technical Forecast Reports - newser.com
Visual trend scoring systems applied to Nurix Therapeutics Inc.Weekly Profit Summary & AI Powered Trade Plan Recommendations - newser.com
Why Nurix Therapeutics Inc. stock is seen as undervalued2025 Biggest Moves & Short-Term Trading Opportunity Alerts - newser.com
How institutional ownership impacts Nurix Therapeutics Inc. stockOptions Play & High Accuracy Swing Trade Signals - newser.com
Is Nurix Therapeutics Inc. building a consolidation baseAnalyst Upgrade & Safe Investment Capital Preservation Plans - newser.com
What technical charts say about Nurix Therapeutics Inc. stockJuly 2025 Recap & Free Technical Pattern Based Buy Signals - newser.com
Will Nurix Therapeutics Inc. stock go up soonJuly 2025 Market Mood & AI Based Buy/Sell Signal Reports - newser.com
Nurix Therapeutics (NASDAQ:NRIX) CFO Houte Hans Van Sells 3,130 Shares - MarketBeat
Nurix Therapeutics (NASDAQ:NRIX) Insider Sells $52,313.60 in Stock - MarketBeat
Nurix Therapeutics Advances NX-5948 Study in B-cell Malignancies - MSN
大文字化:
|
ボリューム (24 時間):